Evolus, Inc.
Evolus, Inc. scores highest on Torque (99) and lowest on Price (0). Its PosiPenta is 60.60 out of 100, better than most similar companies.
On the Penta Grid this week, Evolus, Inc. is Grid #135 of 837 in the Healthcare sector in United States, and Grid #555 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Evolus, Inc. | 60.60 | 0 | 75 | 78 | 99 | 51 |
| Crescent Biopharma, Inc. | 42.73 | 23 | 38 | 42 | 76 | 35 |
| Monopar Therapeutics Inc. | 46.09 | 19 | 30 | 54 | 74 | 53 |
| Neurogene Inc. | 39.06 | 27 | 16 | 53 | 57 | 42 |
| Arvinas, Inc. | 51.64 | 66 | 39 | 35 | 74 | 44 |
| Sight Sciences, Inc. | 45.92 | 8 | 51 | 88 | 36 | 47 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -13.40 |
| P/B ratio | -15.18 |
EEarnings
| Trailing EPS | ₹-50.20 |
| Forward EPS | ₹27.70 |
NNitro
| Price | 672.48 |
| 52-week high | 881.80 |
| 52-week low | 365.60 |
| Fall from 52-week high | 23.7% |
TTorque
| Return on equity (ROE) | — |
| Debt-to-equity | -6.71 |
AAnchor
| Beta (price swings) | 1.34 |
| Market cap | ₹4,441 Cr |
| Insider holding | 11.25% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Evolus, Inc.'s PosiPenta score?
Evolus, Inc.'s PosiPenta is 60.60 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Evolus, Inc. stand on the Penta Grid?
On the Penta Grid this week, Evolus, Inc. is Grid #135 of 837 in the Healthcare sector in United States, and Grid #555 of 4,000 in United States.
Which PosiPenta pillar is strongest for Evolus, Inc.?
Torque (durability), with a score of 99 out of 100: much better than most similar companies.
Which PosiPenta pillar is weakest for Evolus, Inc.?
Price (valuation), with a score of 0 out of 100: much weaker than most similar companies.
Has Evolus, Inc.'s PosiPenta changed since last week?
Yes, it rose 2.53 points, from 58.07 to 60.60.
PositoAI is for research and education only and is not investment advice.